Flying eye hospital heads to China

Article

ORBIS International's Flying Eye Hospital has completed an intensive two-week training programme for approximately 40 ophthalmology residents in Harbin, China.

ORBIS International’s Flying Eye Hospital has completed an intensive two-week training programme for approximately 40 ophthalmology residents in Harbin, China. Approximately 18% of the world’s blind live in China; up to 80% of the country’s ophthalmologists work in urban hospitals, although up to 80% of the 5–6 million blind people live in rural regions.

Although ORBIS frequently conducts training programmes in developing countries around the world, this is the first time the Flying Eye Hospital has been used to train only ophthalmic residency physicians. ORBIS conducted the programme at the request of Heilongjiang Provincial Government, Heilongjiang Provincial Health Bureau, and the Second Affiliated Hospital of Harbin Medical University.

The course, which focused on the treatment and management of paediatric strabismus, glaucoma and cataract (China’s leading cause of blindness), made use of hands-on surgical training, wet labs, live surgical demonstrations, surgical simulator sessions, lectures and workshops for training. ORBIS also conducted clinics on retinal disease and neuro-ophthalmology.

Approximately half of the medical equipment in China does not function correctly. In conjunction with the residents’ training course, ORBIS also repaired critical equipment and provided hands-on training for nine biomedical engineers and technicians, to combat the lack of functioning equipment and continuing education available in this region.

The ORBIS programme in Harbin was sponsored by Alcon, ORBIS’s Alliance for Sight partner.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.